2018
DOI: 10.1016/j.gene.2018.09.005
|View full text |Cite
|
Sign up to set email alerts
|

Association between vascular endothelial growth factor rs699947 polymorphism and the risk of three major urologic neoplasms (bladder cancer, prostate cancer, and renal cell carcinoma): A meta-analysis involving 11,204 subjects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0
1

Year Published

2019
2019
2020
2020

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 50 publications
0
8
0
1
Order By: Relevance
“…The inconclusive roles of SNPs in specific cancer types suggest that pooled analysis is warranted. A meta-analysis containing 11,204 subjects reported that the rs699947 polymorphism within the VEGF (vascular endothelial growth factor) gene was associated with an increased risk of bladder cancer and renal cell carcinoma in Asians [4]. Another meta-analysis with 34,911 cases and 48,329 controls showed the genetic relationship between the BRCA2 (BRCA2 DNA repair associated) rs144848 polymorphism and the overall risk of cancer [5].…”
Section: Introductionmentioning
confidence: 99%
“…The inconclusive roles of SNPs in specific cancer types suggest that pooled analysis is warranted. A meta-analysis containing 11,204 subjects reported that the rs699947 polymorphism within the VEGF (vascular endothelial growth factor) gene was associated with an increased risk of bladder cancer and renal cell carcinoma in Asians [4]. Another meta-analysis with 34,911 cases and 48,329 controls showed the genetic relationship between the BRCA2 (BRCA2 DNA repair associated) rs144848 polymorphism and the overall risk of cancer [5].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, VEGFA was modulated by apigenin (MOL009) and luteolin (MOL022). It has been reported in literature that VEGFA has many functions such as increasing vascular permeability, inducing angiogenesis, angiogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis [58][59][60]. us, these above analyses show that compound may treat NSCLC by regulating the angiogenesis, migration, and invasion.…”
Section: Invasion Modulementioning
confidence: 89%
“…E2F1 gene polymorphism is considered to be associated with lung cancer head and neck cancer and other cancers. VEGFA gene polymorphism has been confirmed to be associated with metastatic colorectal cancer bladder cancer, renal cell carcinoma, prostate cancer and other cancers (32)(33)(34)(35). FOXO 3a plays an inhibitory role in cancer and is closely related to malignant tumors such as breast cancer, colon cancer, prostate cancer, bladder cancer and nasopharyngeal carcinoma (36).…”
Section: Discussionmentioning
confidence: 99%